Overview of Preoperative Structural Imaging Features in ppCMS Compared With Non-ppCMS Patients
Preoperative structural imaging—ppCMS compared with non-ppCMS patients . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Author . | Year . | Modality . | Lesion localization . | Involvement/ invasion/ compression/ injury . | QUIPS Overall Risk of Bias . | |||||
CH . | 4V and/or V . | Brainstem . | SCP . | MCP . | Cerebellar nuclei . | ION . | ||||
Boisgontier et al.23 | 2021 | MRI (ASL/ T2W) | ns | V ns | - | ns | ns | DN ns | - | Low Risk |
Liu et al.24 | 2018 | MRI (NM) | ↓* | ↑ 4V* | ↑ns | ↑L ↑R ns | ↑BI* | DN ↑L*↑R* | - | Low Risk |
Toescu et al.25 | 2018 | MRI (T1W/T2W/ FLAIR/DWI) | - | - | - | ns | - | DN & RN ns | - | Low Risk |
Yang et al.26 | 2023 | MRI (T1w/T2W/ FLAIR) | ↑L* ↑R* superior | ↑V* | ↑* | ↑R* > ↑L* | - | - | - | Low Risk |
Catsman-Berrevoets et al.27 | 1999 | CT & MRI (NM) | ↓* | ↑4V/V* | - | - | - | - | - | Moderate Risk |
de Laurentis et al.28 | 2022 | MRI (NM) | ↑4V*↑V ns | ↑ ns | ↑R* | ↑R* | - | - | Moderate Risk | |
Dhaenens et al.29 | 2020 | MRI (NM) | ↓* | ↑4V* | ↑* | ↑R* > ↑L* | ↑R* > ↑L* | - | - | Moderate Risk |
Kotil et al.30 | 2008 | CT & MRI (NM) | ↓* | ↑4V/V* | - | - | - | - | - | Moderate Risk |
McEvoy et al.31 | 2016 | MRI (DTI/ MPRAGE (T1W)) | - | - | ns | - | - | - | - | Moderate Risk |
McMillan et al.32 | 2009 | MRI (T1W/T2W) | - | - | ↑* | - | - | - | - | Moderate Risk |
Morris et al.33 | 2009 | MRI (DTI/T2W) | ↑4V (rostal)* | ns | ns | ns | DN ns | - | Moderate Risk | |
Pols et al.34 | 2017 | MRI (T1W/T1W-C/ T2W/FLAIR) | - | - | ↑* | - | - | - | - | Moderate Risk |
Ruella et al.35 | 2023 | MRI (NM) | ↓* | ↑ 4V/ V* | ↑* | - | - | - | - | Moderate Risk |
Wells et al.36 | 2010 | MRI (T1W/T2W/T1W-C) | - | - | ↑* | - | - | - | - | Moderate Risk |
Yang et al.37 | 2023 | T1W/T2W/ FLAIR/DWI | - | ↑4V/V* | - | - | - | - | - | Moderate Risk |
Doxey et al.38 | 1999 | MRI (NM) | - | - | ↑* | - | - | - | - | High Risk |
Gora et al.39 | 2017 | CT &MRI (NM) | - | - | ns | ns | ns | - | High Risk | |
Ma et al.40 | 2019 | MRI (NM) | - | ↑4V* | - | - | - | - | - | High Risk |
Renne et al.3 | 2020 | MRI (NM) | - | - | ↑* | - | - | - | - | High Risk |
Schmidt et al.41 | 2023 | MRI (NM) | ↓ns | ↑4V/V ns | ns | - | - | - | - | High Risk |
Sergeant et al.42 | 2017 | MRI (T1w/T1w-C/ T2W/DWI/ FLAIR) | - | ↑4V ns | - | - | - | - | - | High Risk |
Siffert et al.43 | 2000 | CT & MRI (NM) | ↑edema ns | - | ↑edema ns | - | - | DN ns | - | High Risk |
Zhang et al.44 | 2019 | CT & MRI (NM) | ↑compression* | - | ↑* | - | - | - | - | High Risk |
Preoperative structural imaging—ppCMS compared with non-ppCMS patients . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Author . | Year . | Modality . | Lesion localization . | Involvement/ invasion/ compression/ injury . | QUIPS Overall Risk of Bias . | |||||
CH . | 4V and/or V . | Brainstem . | SCP . | MCP . | Cerebellar nuclei . | ION . | ||||
Boisgontier et al.23 | 2021 | MRI (ASL/ T2W) | ns | V ns | - | ns | ns | DN ns | - | Low Risk |
Liu et al.24 | 2018 | MRI (NM) | ↓* | ↑ 4V* | ↑ns | ↑L ↑R ns | ↑BI* | DN ↑L*↑R* | - | Low Risk |
Toescu et al.25 | 2018 | MRI (T1W/T2W/ FLAIR/DWI) | - | - | - | ns | - | DN & RN ns | - | Low Risk |
Yang et al.26 | 2023 | MRI (T1w/T2W/ FLAIR) | ↑L* ↑R* superior | ↑V* | ↑* | ↑R* > ↑L* | - | - | - | Low Risk |
Catsman-Berrevoets et al.27 | 1999 | CT & MRI (NM) | ↓* | ↑4V/V* | - | - | - | - | - | Moderate Risk |
de Laurentis et al.28 | 2022 | MRI (NM) | ↑4V*↑V ns | ↑ ns | ↑R* | ↑R* | - | - | Moderate Risk | |
Dhaenens et al.29 | 2020 | MRI (NM) | ↓* | ↑4V* | ↑* | ↑R* > ↑L* | ↑R* > ↑L* | - | - | Moderate Risk |
Kotil et al.30 | 2008 | CT & MRI (NM) | ↓* | ↑4V/V* | - | - | - | - | - | Moderate Risk |
McEvoy et al.31 | 2016 | MRI (DTI/ MPRAGE (T1W)) | - | - | ns | - | - | - | - | Moderate Risk |
McMillan et al.32 | 2009 | MRI (T1W/T2W) | - | - | ↑* | - | - | - | - | Moderate Risk |
Morris et al.33 | 2009 | MRI (DTI/T2W) | ↑4V (rostal)* | ns | ns | ns | DN ns | - | Moderate Risk | |
Pols et al.34 | 2017 | MRI (T1W/T1W-C/ T2W/FLAIR) | - | - | ↑* | - | - | - | - | Moderate Risk |
Ruella et al.35 | 2023 | MRI (NM) | ↓* | ↑ 4V/ V* | ↑* | - | - | - | - | Moderate Risk |
Wells et al.36 | 2010 | MRI (T1W/T2W/T1W-C) | - | - | ↑* | - | - | - | - | Moderate Risk |
Yang et al.37 | 2023 | T1W/T2W/ FLAIR/DWI | - | ↑4V/V* | - | - | - | - | - | Moderate Risk |
Doxey et al.38 | 1999 | MRI (NM) | - | - | ↑* | - | - | - | - | High Risk |
Gora et al.39 | 2017 | CT &MRI (NM) | - | - | ns | ns | ns | - | High Risk | |
Ma et al.40 | 2019 | MRI (NM) | - | ↑4V* | - | - | - | - | - | High Risk |
Renne et al.3 | 2020 | MRI (NM) | - | - | ↑* | - | - | - | - | High Risk |
Schmidt et al.41 | 2023 | MRI (NM) | ↓ns | ↑4V/V ns | ns | - | - | - | - | High Risk |
Sergeant et al.42 | 2017 | MRI (T1w/T1w-C/ T2W/DWI/ FLAIR) | - | ↑4V ns | - | - | - | - | - | High Risk |
Siffert et al.43 | 2000 | CT & MRI (NM) | ↑edema ns | - | ↑edema ns | - | - | DN ns | - | High Risk |
Zhang et al.44 | 2019 | CT & MRI (NM) | ↑compression* | - | ↑* | - | - | - | - | High Risk |
↑More involvement of the region in ppCMS compared with non-ppCMS patients;
↓Less involvement of the region in ppCMS compared with non-ppCMS patients.
*Significant results; ns, nonsignificant; -, not measured.
4V, 4th ventricle; ASL, arterial spin labeling; BI, bilateral; CH, cerebellar hemisphere; DN, dentate nucleus; DTI, diffusion tensor imaging; DWI, diffusion weighted imaging; FLAIR, fluid attenuation inversion recovery; ION, inferior olivary nucleus; MCP, middle cerebellar peduncle; NM, not mentioned; PD, proton density; RN, red nucleus; SCP, superior cerebellar peduncle; T1W-C, T1-weighted imaging with contrast; T1W, T1-weighted imaging; T2W, T2-weighted imaging; UNI, unilateral; V, vermis.
Overview of Preoperative Structural Imaging Features in ppCMS Compared With Non-ppCMS Patients
Preoperative structural imaging—ppCMS compared with non-ppCMS patients . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Author . | Year . | Modality . | Lesion localization . | Involvement/ invasion/ compression/ injury . | QUIPS Overall Risk of Bias . | |||||
CH . | 4V and/or V . | Brainstem . | SCP . | MCP . | Cerebellar nuclei . | ION . | ||||
Boisgontier et al.23 | 2021 | MRI (ASL/ T2W) | ns | V ns | - | ns | ns | DN ns | - | Low Risk |
Liu et al.24 | 2018 | MRI (NM) | ↓* | ↑ 4V* | ↑ns | ↑L ↑R ns | ↑BI* | DN ↑L*↑R* | - | Low Risk |
Toescu et al.25 | 2018 | MRI (T1W/T2W/ FLAIR/DWI) | - | - | - | ns | - | DN & RN ns | - | Low Risk |
Yang et al.26 | 2023 | MRI (T1w/T2W/ FLAIR) | ↑L* ↑R* superior | ↑V* | ↑* | ↑R* > ↑L* | - | - | - | Low Risk |
Catsman-Berrevoets et al.27 | 1999 | CT & MRI (NM) | ↓* | ↑4V/V* | - | - | - | - | - | Moderate Risk |
de Laurentis et al.28 | 2022 | MRI (NM) | ↑4V*↑V ns | ↑ ns | ↑R* | ↑R* | - | - | Moderate Risk | |
Dhaenens et al.29 | 2020 | MRI (NM) | ↓* | ↑4V* | ↑* | ↑R* > ↑L* | ↑R* > ↑L* | - | - | Moderate Risk |
Kotil et al.30 | 2008 | CT & MRI (NM) | ↓* | ↑4V/V* | - | - | - | - | - | Moderate Risk |
McEvoy et al.31 | 2016 | MRI (DTI/ MPRAGE (T1W)) | - | - | ns | - | - | - | - | Moderate Risk |
McMillan et al.32 | 2009 | MRI (T1W/T2W) | - | - | ↑* | - | - | - | - | Moderate Risk |
Morris et al.33 | 2009 | MRI (DTI/T2W) | ↑4V (rostal)* | ns | ns | ns | DN ns | - | Moderate Risk | |
Pols et al.34 | 2017 | MRI (T1W/T1W-C/ T2W/FLAIR) | - | - | ↑* | - | - | - | - | Moderate Risk |
Ruella et al.35 | 2023 | MRI (NM) | ↓* | ↑ 4V/ V* | ↑* | - | - | - | - | Moderate Risk |
Wells et al.36 | 2010 | MRI (T1W/T2W/T1W-C) | - | - | ↑* | - | - | - | - | Moderate Risk |
Yang et al.37 | 2023 | T1W/T2W/ FLAIR/DWI | - | ↑4V/V* | - | - | - | - | - | Moderate Risk |
Doxey et al.38 | 1999 | MRI (NM) | - | - | ↑* | - | - | - | - | High Risk |
Gora et al.39 | 2017 | CT &MRI (NM) | - | - | ns | ns | ns | - | High Risk | |
Ma et al.40 | 2019 | MRI (NM) | - | ↑4V* | - | - | - | - | - | High Risk |
Renne et al.3 | 2020 | MRI (NM) | - | - | ↑* | - | - | - | - | High Risk |
Schmidt et al.41 | 2023 | MRI (NM) | ↓ns | ↑4V/V ns | ns | - | - | - | - | High Risk |
Sergeant et al.42 | 2017 | MRI (T1w/T1w-C/ T2W/DWI/ FLAIR) | - | ↑4V ns | - | - | - | - | - | High Risk |
Siffert et al.43 | 2000 | CT & MRI (NM) | ↑edema ns | - | ↑edema ns | - | - | DN ns | - | High Risk |
Zhang et al.44 | 2019 | CT & MRI (NM) | ↑compression* | - | ↑* | - | - | - | - | High Risk |
Preoperative structural imaging—ppCMS compared with non-ppCMS patients . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Author . | Year . | Modality . | Lesion localization . | Involvement/ invasion/ compression/ injury . | QUIPS Overall Risk of Bias . | |||||
CH . | 4V and/or V . | Brainstem . | SCP . | MCP . | Cerebellar nuclei . | ION . | ||||
Boisgontier et al.23 | 2021 | MRI (ASL/ T2W) | ns | V ns | - | ns | ns | DN ns | - | Low Risk |
Liu et al.24 | 2018 | MRI (NM) | ↓* | ↑ 4V* | ↑ns | ↑L ↑R ns | ↑BI* | DN ↑L*↑R* | - | Low Risk |
Toescu et al.25 | 2018 | MRI (T1W/T2W/ FLAIR/DWI) | - | - | - | ns | - | DN & RN ns | - | Low Risk |
Yang et al.26 | 2023 | MRI (T1w/T2W/ FLAIR) | ↑L* ↑R* superior | ↑V* | ↑* | ↑R* > ↑L* | - | - | - | Low Risk |
Catsman-Berrevoets et al.27 | 1999 | CT & MRI (NM) | ↓* | ↑4V/V* | - | - | - | - | - | Moderate Risk |
de Laurentis et al.28 | 2022 | MRI (NM) | ↑4V*↑V ns | ↑ ns | ↑R* | ↑R* | - | - | Moderate Risk | |
Dhaenens et al.29 | 2020 | MRI (NM) | ↓* | ↑4V* | ↑* | ↑R* > ↑L* | ↑R* > ↑L* | - | - | Moderate Risk |
Kotil et al.30 | 2008 | CT & MRI (NM) | ↓* | ↑4V/V* | - | - | - | - | - | Moderate Risk |
McEvoy et al.31 | 2016 | MRI (DTI/ MPRAGE (T1W)) | - | - | ns | - | - | - | - | Moderate Risk |
McMillan et al.32 | 2009 | MRI (T1W/T2W) | - | - | ↑* | - | - | - | - | Moderate Risk |
Morris et al.33 | 2009 | MRI (DTI/T2W) | ↑4V (rostal)* | ns | ns | ns | DN ns | - | Moderate Risk | |
Pols et al.34 | 2017 | MRI (T1W/T1W-C/ T2W/FLAIR) | - | - | ↑* | - | - | - | - | Moderate Risk |
Ruella et al.35 | 2023 | MRI (NM) | ↓* | ↑ 4V/ V* | ↑* | - | - | - | - | Moderate Risk |
Wells et al.36 | 2010 | MRI (T1W/T2W/T1W-C) | - | - | ↑* | - | - | - | - | Moderate Risk |
Yang et al.37 | 2023 | T1W/T2W/ FLAIR/DWI | - | ↑4V/V* | - | - | - | - | - | Moderate Risk |
Doxey et al.38 | 1999 | MRI (NM) | - | - | ↑* | - | - | - | - | High Risk |
Gora et al.39 | 2017 | CT &MRI (NM) | - | - | ns | ns | ns | - | High Risk | |
Ma et al.40 | 2019 | MRI (NM) | - | ↑4V* | - | - | - | - | - | High Risk |
Renne et al.3 | 2020 | MRI (NM) | - | - | ↑* | - | - | - | - | High Risk |
Schmidt et al.41 | 2023 | MRI (NM) | ↓ns | ↑4V/V ns | ns | - | - | - | - | High Risk |
Sergeant et al.42 | 2017 | MRI (T1w/T1w-C/ T2W/DWI/ FLAIR) | - | ↑4V ns | - | - | - | - | - | High Risk |
Siffert et al.43 | 2000 | CT & MRI (NM) | ↑edema ns | - | ↑edema ns | - | - | DN ns | - | High Risk |
Zhang et al.44 | 2019 | CT & MRI (NM) | ↑compression* | - | ↑* | - | - | - | - | High Risk |
↑More involvement of the region in ppCMS compared with non-ppCMS patients;
↓Less involvement of the region in ppCMS compared with non-ppCMS patients.
*Significant results; ns, nonsignificant; -, not measured.
4V, 4th ventricle; ASL, arterial spin labeling; BI, bilateral; CH, cerebellar hemisphere; DN, dentate nucleus; DTI, diffusion tensor imaging; DWI, diffusion weighted imaging; FLAIR, fluid attenuation inversion recovery; ION, inferior olivary nucleus; MCP, middle cerebellar peduncle; NM, not mentioned; PD, proton density; RN, red nucleus; SCP, superior cerebellar peduncle; T1W-C, T1-weighted imaging with contrast; T1W, T1-weighted imaging; T2W, T2-weighted imaging; UNI, unilateral; V, vermis.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.